Pragmatic, double-blind, randomised trial evaluating the impact of red blood cell donor sex on recipient mortality in an academic hospital population: the innovative Trial Assessing Donor Sex (iTADS) protocol

Dean A Fergusson, Michael Chassé, Alan Tinmouth, Jason P Acker, Shane English, Alan J Forster, Steven Hawken, Nadine Shehata, Kednapa Thavorn, Kumanan Wilson, Angie Tuttle, Iris Perelman, Nancy Cober, Heather Maddison, Melanie Tokessy, Dean A Fergusson, Michael Chassé, Alan Tinmouth, Jason P Acker, Shane English, Alan J Forster, Steven Hawken, Nadine Shehata, Kednapa Thavorn, Kumanan Wilson, Angie Tuttle, Iris Perelman, Nancy Cober, Heather Maddison, Melanie Tokessy

Abstract

Introduction: With over 1 million units of blood transfused each year in Canada, their use has a significant clinical and economic impact on our health system. Adequate screening of blood donors is important to ensure the safety and clinical benefit of blood products. Some adverse transfusion reactions have been shown to be related to donor factors (eg, lung injury), whereas other adverse outcomes have been theoretically related to donor factors (mortality and infection). Our clinical trial will test whether male donor blood leads to a greater benefit for transfusion recipients compared with female donor blood.

Methods and analysis: We have designed a pragmatic, double-blind, randomised trial that will allocate transfusion recipients to receive either male-only or female-only donor transfusions. We will enrol 8850 adult patients requiring at least one transfusion at four sites over an approximate 2-year period. Randomisation and allocation will occur in the blood bank prior to release of the units of blood for transfusion. Our primary outcome is mortality. An intent-to-treat analysis will be applied using all randomised and transfused patients. The principal analysis will be a survival analysis comparing the time from randomisation to death between patients allocated to male donor red blood cells (RBCs) and female donor RBCs.

Ethics and dissemination: Approval has been obtained from research ethics boards of all involved institutions, as well as from privacy offices of Canadian Blood Services, Institute for Clinical Evaluative Science and The Ottawa Hospital Data Warehouse. Our findings will be published in peer-reviewed journals and presented at relevant stakeholder conferences and meetings.

Trial registration number: NCT03344887; Pre-results.

Keywords: anaemia; blood bank & transfusion medicine; clinical trials.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest 2005;127:295–307. 10.1378/chest.127.1.295
    1. Bennett-Guerrero E, Zhao Y, O'Brien SM, et al. . Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010;304:1568–75. 10.1001/jama.2010.1406
    1. Hébert PC, Wells G, Blajchman MA, et al. . A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. transfusion requirements in critical care Investigators, Canadian critical care Trials Group. N Engl J Med 1999;340:409–17. 10.1056/NEJM199902113400601
    1. Hajjar LA, Vincent J-L, Galas FRBG, et al. . Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010;304:1559–67. 10.1001/jama.2010.1446
    1. Carson JL, Terrin ML, Noveck H, et al. . Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365:2453–62. 10.1056/NEJMoa1012452
    1. Gilliss BM, Looney MR, Gropper MA. Reducing noninfectious risks of blood transfusion. Anesthesiology 2011;115:635–49. 10.1097/ALN.0b013e31822a22d9
    1. Vamvakas EC, Blajchman MA, a BM. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009;113:3406–17. 10.1182/blood-2008-10-167643
    1. O'Brien SF, Yi Q-L, Fan W, et al. . Current incidence and residual risk of HIV, HBV and HCV at Canadian blood services. Vox Sang 2012;103:83–6. 10.1111/j.1423-0410.2012.01584.x
    1. Chassé M, McIntyre L, English SW, et al. . Effect of blood donor characteristics on transfusion outcomes: a systematic review and meta-analysis. Transfus Med Rev 2016;30:69–80. 10.1016/j.tmrv.2016.01.002
    1. Zeller MP, Rochwerg B, Jamula E, et al. . Sex-mismatched red blood cell transfusions and mortality: a systematic review and meta-analysis. Vox Sang 2019;114:505–16. 10.1111/vox.12783
    1. Chassé M, Tinmouth A, English SW, et al. . Association of blood donor age and sex with recipient survival after red blood cell transfusion. JAMA Intern Med 2016;176:1307. 10.1001/jamainternmed.2016.3324
    1. Toy P, Gajic O, Bacchetti P, et al. . Transfusion-related acute lung injury: incidence and risk factors. Blood 2012;119:1757–67. 10.1182/blood-2011-08-370932
    1. Lin Y, Saw C-L, Hannach B, et al. . Transfusion-related acute lung injury prevention measures and their impact at Canadian blood services. Transfusion 2012;52:567–74. 10.1111/j.1537-2995.2011.03330.x
    1. Caram-Deelder C, Kreuger AL, Evers D, et al. . Association of blood transfusion from female donors with and without a history of pregnancy with mortality among male and female transfusion recipients. JAMA 2017;318:1471. [Published correction appears in JAMA. 2018 Feb 20; 319(7): 724]. 10.1001/jama.2017.14825
    1. Chassé M, McIntyre L, Tinmouth A, et al. . Clinical effects of blood donor characteristics in transfusion recipients: protocol of a framework to study the blood donor-recipient continuum. BMJ Open 2015;5:e007412. 10.1136/bmjopen-2014-007412
    1. Kollman C, Howe CW, Anasetti C, et al. . Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001;98:2043–51. 10.1182/blood.V98.7.2043
    1. Edgren G, Murphy EL, Brambilla DJ, et al. . Association of blood donor sex and prior pregnancy with mortality among red blood cell transfusion recipients. JAMA 2019;321:2183–92. 10.1001/jama.2019.7084
    1. Edgren G, Ullum H, Rostgaard K, et al. . Association of donor age and sex with survival of patients receiving transfusions. JAMA Intern Med 2017;177:854–60. 10.1001/jamainternmed.2017.0890
    1. Pfuntner A, Wier L, Stocks C. Most frequent procedures performed in US. hospitals 2013;2010.
    1. Tri-Council Policy Statement . Ethical conduct for research involving humans. Ottawa, 2014.
    1. Eikelboom JW, Cook RJ, Barty R, et al. . Rationale and design of the informing fresh versus old red cell management (inform) trial: an international pragmatic randomized trial. Transfus Med Rev 2016;30:25–9. 10.1016/j.tmrv.2015.11.002
    1. Iron K, Zagorski B, Sykora K, et al. . Living and dying in Ontario: an opportunity for. Toronto: Improved Health Information, 2008.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner